Addus HomeCare (NASDAQ:ADUS) Announces Quarterly Earnings Results

Addus HomeCare (NASDAQ:ADUS) announced its quarterly earnings results on Tuesday. The company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04, FiscalAI reports. The firm had revenue of $387.74 million for the quarter, compared to the consensus estimate of $388.72 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%.

Addus HomeCare Stock Performance

ADUS traded up $0.80 during midday trading on Tuesday, reaching $126.55. The company had a trading volume of 453,570 shares, compared to its average volume of 235,769. The business has a 50-day moving average of $117.10 and a two-hundred day moving average of $106.54. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $127.08. The company has a market cap of $2.36 billion, a P/E ratio of 22.20, a P/E/G ratio of 1.74 and a beta of 0.83.

Analyst Ratings Changes

Several research firms have recently weighed in on ADUS. Royal Bank Of Canada boosted their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Barclays lifted their target price on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Citigroup cut Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. Weiss Ratings raised Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. Finally, Raymond James Financial set a $137.00 price objective on Addus HomeCare in a research report on Monday, September 28th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $129.33.

About Addus HomeCare

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.